Clinical Trial Update: SKB264 Injection vs Investigator Selected Regimens to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing SKB264 injection against investigator-selected regimens for locally advanced, recurrent, or metastatic triple-negative breast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• SKB264

Snippet

Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Conditions: Triple Negative Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING